Search Results 2081-2090 of 24183 for autoimmune hepatitis

1. Inflammatory bowel disease (IBD) - Diagnosis and treatment - Mayo Clinic

   Have you ever had liver problems, hepatitis or jaundice? Have you had ... In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, ...

2. Metoclopramide (nasal route) - Side effects & dosage - Mayo Clinic

   Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Pheochromocytoma (adrenal gland tumor) or ...

3. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   ... autoimmune thyroid disease, vasculitis, or glomerulonephritis: Patients with a history of autoimmune ... Active hepatitis B virus (HBV) infection, defined as ...

4. Telaprevir (oral route) - Side effects & dosage - Mayo Clinic

   ... hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received ...

5. Rory L. Smoot, M.D. - Doctors and Medical Staff - Mayo Clinic

   Pancreatitis; Peritoneal cancer; Polycystic liver disease ... Benign Conditions of the Liver and Bile Ducts (Hemangioma, Bile duct injury, Polycystic liver ...

6. Hepatitis b immune globulin (intramuscular route, intravenous route) - Side effects & uses - Mayo Clinic

   Sexual partners of persons with hepatitis B. Persons who may be exposed to the virus by means of blood, blood products, or human bites, such as health care ...

7. A Study Evaluating Efruxifermin In Subjects With Compensated Cirrhosis Due To NASH/MASH - Mayo Clinic

   * Any current or prior history of decompensated liver disease Other inclusion and exclusion criteria may apply. Note: Other protocol defined Inclusion ...

8. A Study to Evaluate Diagnostic Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® in Patients Scheduled for a Liver Biopsy - Mayo Clinic

   ... liver disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

9. Deucravacitinib (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (eg, hepatitis B or C) or; Tuberculosis, history of—Use with caution. May make these conditions worse. Infection, active or; Liver disease ...

10. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

    Autoimmune disease (including any history of ... autoimmune disease. ... Patients with known hepatitis B (HepBsAg+) who have controlled infection (serum hepatitis ...